Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Circulation. 2016 Dec 13; 134(24):1931-1943.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Apolipoprotein B-100
Body Mass Index
Cardiovascular Diseases
Cholesterol, LDL
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Ezetimibe
Female
Follow-Up Studies
Humans
Lipids
Male
Middle Aged
Placebo Effect
Prospective Studies
Treatment Outcome

authors with profiles

Michael H. Davidson